DE3033545A1 - Verwendung bekannter antiallergener mittel bei der bekaempfung von pathologischen mineralresorptionszustaenden - Google Patents
Verwendung bekannter antiallergener mittel bei der bekaempfung von pathologischen mineralresorptionszustaendenInfo
- Publication number
- DE3033545A1 DE3033545A1 DE19803033545 DE3033545A DE3033545A1 DE 3033545 A1 DE3033545 A1 DE 3033545A1 DE 19803033545 DE19803033545 DE 19803033545 DE 3033545 A DE3033545 A DE 3033545A DE 3033545 A1 DE3033545 A1 DE 3033545A1
- Authority
- DE
- Germany
- Prior art keywords
- conditions
- pathological
- resorption
- pathological mineral
- states
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7339879A | 1979-09-07 | 1979-09-07 | |
US7340079A | 1979-09-07 | 1979-09-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3033545A1 true DE3033545A1 (de) | 1981-04-02 |
Family
ID=26754428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19803033545 Withdrawn DE3033545A1 (de) | 1979-09-07 | 1980-09-05 | Verwendung bekannter antiallergener mittel bei der bekaempfung von pathologischen mineralresorptionszustaenden |
Country Status (8)
Country | Link |
---|---|
JP (1) | JPS5649317A (nl) |
AU (1) | AU532512B2 (nl) |
BE (1) | BE885113A (nl) |
DE (1) | DE3033545A1 (nl) |
FR (1) | FR2464716B1 (nl) |
GB (1) | GB2058564B (nl) |
IT (1) | IT1174303B (nl) |
NL (1) | NL8004904A (nl) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4764334A (en) * | 1983-10-17 | 1988-08-16 | Westinghouse Electric Corp. | Visual inspection system for radioactive fuel assemblies using fiberoptics |
US4997824A (en) * | 1987-07-22 | 1991-03-05 | Teva Pharmaceutical Industries Ltd. | Combination of cholecalciferol derivatives for the treatment of renal bone disease |
US4911931A (en) * | 1987-08-03 | 1990-03-27 | Baylink David J | Pharmaceutical combination for treatment of bone-wasting diseases |
US5013728A (en) * | 1990-05-04 | 1991-05-07 | Colgate - Palmolive Company | Composition for treating osteoporosis and hormonal imbalance |
US5710144A (en) * | 1993-02-08 | 1998-01-20 | Akzo Nobel N.V. | C-11 substituted steroids for treating menopausal complaints |
ZA94715B (en) * | 1993-02-08 | 1994-10-24 | Akzo Nv | Steroids for treating menopausal complaints |
US6037339A (en) | 1993-02-08 | 2000-03-14 | Akzo Nobel N.V. | C-11 substituted steroids for treating menopausal complaints |
EP0973513A4 (en) * | 1996-10-23 | 2003-03-19 | Zymogenetics Inc | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH BONE DEFICIT |
DE19832169A1 (de) * | 1998-07-17 | 2000-01-27 | Jenapharm Gmbh | Lokal anwendbare pharmazeutische Präparate zur Prophylaxe und Therapie atrophischer Erscheinungen in der Mundhöhle |
EP1162890B1 (en) | 1998-10-30 | 2005-10-12 | RJ Innovation | A method of preventing parturient hypocalcemia in animals and compositions used therein |
WO2000067708A2 (en) * | 1999-05-07 | 2000-11-16 | Board Of Regents, The University Of Texas System | Oral steroidal hormone compositions and methods of use |
MXPA05014091A (es) * | 2005-12-20 | 2007-06-20 | Leopoldo De Jesus Espinosa Abdala | Composiciones farmaceuticas que comprenden derivados de esteroides sinteticos, minerales y el metabolito activo de la vitamina d, 1,25(oh)2d3 (calcitriol) para la prevencion y tratamiento de la osteoporosis y el control de los sintomas de la menopaus |
CN111602630A (zh) * | 2020-06-24 | 2020-09-01 | 山西农业大学 | 呕吐毒素致肉鸡小肠机械性损伤模型的建立方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1473318A (en) * | 1973-05-25 | 1977-05-11 | Fisons Ltd | Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof |
US4029761A (en) * | 1974-10-19 | 1977-06-14 | Fisons Limited | Method for treating gingivitis |
IE41922B1 (en) * | 1974-11-09 | 1980-04-23 | Fisons Ltd | Pharmaceutical compositions containing bis-chromones |
-
1980
- 1980-08-28 AU AU61843/80A patent/AU532512B2/en not_active Ceased
- 1980-08-29 NL NL8004904A patent/NL8004904A/nl not_active Application Discontinuation
- 1980-09-05 GB GB8028763A patent/GB2058564B/en not_active Expired
- 1980-09-05 IT IT49625/80A patent/IT1174303B/it active
- 1980-09-05 FR FR8019237A patent/FR2464716B1/fr not_active Expired
- 1980-09-05 DE DE19803033545 patent/DE3033545A1/de not_active Withdrawn
- 1980-09-05 BE BE0/202008A patent/BE885113A/fr not_active IP Right Cessation
- 1980-09-08 JP JP12448280A patent/JPS5649317A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU6184380A (en) | 1981-03-12 |
JPS5649317A (en) | 1981-05-02 |
IT8049625A0 (it) | 1980-09-05 |
FR2464716B1 (fr) | 1985-10-25 |
GB2058564B (en) | 1983-10-26 |
BE885113A (fr) | 1981-03-05 |
GB2058564A (en) | 1981-04-15 |
AU532512B2 (en) | 1983-10-06 |
NL8004904A (nl) | 1981-03-10 |
FR2464716A1 (fr) | 1981-03-20 |
IT1174303B (it) | 1987-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60113537T2 (de) | Methode zur verabreichung von biphosphonaten | |
DE69629184T2 (de) | Verwendung von vitamin d2 oder vitamin d4-derivaten zur herstellung eines medikamentes zur behandlung des sekundären hyperparathyroidismus | |
DE3686343T2 (de) | Pharmazeutische zubereitung zur anwendung fuer die anreicherung von knochenmasse. | |
DE69822665T2 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
DE69328771T2 (de) | Verfahren zur hemmung der karzinogenese durch behandlung mit dehydroepiandrosteron und dessen analoge | |
DE69016768T2 (de) | Zusammensetzung und Verfahren für die Behandlung von Osteoporose bei Säugetieren. | |
DE69404675T2 (de) | Pharmazeutische zusammensetzung zur intranasalen verabreichung von hydroxocobalamin | |
DE69201725T2 (de) | Behandlungsmethoden für osteoporose. | |
DE69113386T2 (de) | Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern. | |
DE3428729A1 (de) | Mittel zur verhinderung oder inhibierung einer alveolaeren knochenresorption | |
DE69826132T2 (de) | Pharmazeutisches kombinationspräparat aus parathormon und einem inhibitor der knochenresorption | |
DE3033545A1 (de) | Verwendung bekannter antiallergener mittel bei der bekaempfung von pathologischen mineralresorptionszustaenden | |
DE60218842T2 (de) | Orale verabreichung von parathyroidhormon und calcitonin | |
DE3201865C2 (de) | Verwendung von 6-Amino-1-hydroxyhexan-1,1- diphosphonsäure und Derivaten davon zur Behandlung der Osteopathie | |
DE69612510T2 (de) | Verwendung von 1-(2-naphtylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridin zur herstellung eines medikaments zur behandlung der amyotrophen lateralsklerode | |
EP0236390B1 (de) | Mittel gegen multiple sklerose | |
DE69200757T2 (de) | Pharmazeutische Zusammensetzung zur Inhibierung der Knochenresorption. | |
DE69023939T2 (de) | Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten. | |
DE69301750T2 (de) | Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose | |
DE68919673T2 (de) | Verfahren zur behandlung und vorbeugung des verlustes von knochenmasse. | |
DE60212710T2 (de) | Pharmazeutische zubereitungen enthaltend epothilone und deren verwendung bei der behandlung von karzinoid | |
DE69125204T2 (de) | Therapeutische Anwendung von Histamin-H3-Agonisten, neue Wirkstoffe und Verwendung zur Herstellung von Arzneimitteln | |
DE2366498C2 (nl) | ||
US4501754A (en) | Methods of treating bone resorption | |
DE10156617A1 (de) | Herstellung reiner Stereoisomere von Tricyclo[5.2.1.0··2··.··6··]-dec-9-yl-xanthogenat und Arzneimittel daraus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8128 | New person/name/address of the agent |
Representative=s name: HENKEL, G., DR.PHIL. FEILER, L., DR.RER.NAT. HAENZ |
|
8141 | Disposal/no request for examination |